Annual Plasma Neurofilament Dynamics Is a Sensitive Biomarker of Disease Activity in Patients with Multiple Sclerosis

Annual Plasma Neurofilament Dynamics Is a Sensitive Biomarker of Disease Activity in Patients with Multiple Sclerosis

<i>Background and Objectives</i>: Neurofilament light chain (NfL) is a sensitive biomarker of neuroaxonal damage. This study aimed to assess the relationship between the annual change in plasma NfL (pNfL) and disease activity in the past year, as defined by the concept no evidence of dis...

Full description

Bibliographic Details
Main Authors:	Miriam Fedičová, Pavol Mikula, Zuzana Gdovinová, Marianna Vitková, Norbert Žilka, Jozef Hanes, Lýdia Frigová, Jarmila Szilasiová
Format:	Article
Language:	English
Published:	MDPI AG 2023-04-01
Series:	Medicina
Subjects:	multiple sclerosis disease activity neurofilament light chain neurofilament dynamics NEDA
Online Access:	https://www.mdpi.com/1648-9144/59/5/865

Similar Items

Associations between neurofilament light chain levels, disease activity and brain atrophy in progressive multiple sclerosis
by: Jarmila Szilasiova, et al.
Published: (2022-09-01)

The diagnostic significance of neurofilament heavy chains in cerebrospinal fluid in amyotrophic lateral sclerosis
by: Anastasia V. Vladykina, et al.
Published: (2021-03-01)

Depression and anxiety disorders in patients with multiple sclerosis: association with neurodegeneration and neurofilaments
by: C.B. Tauil, et al.
Published: (2021-01-01)

Current application of neurofilaments in amyotrophic lateral sclerosis and future perspectives
by: Yuri Matteo Falzone, et al.
Published: (2021-01-01)

Functional Characterization of Neurofilament Light Splicing and Misbalance in Zebrafish
by: Doris Lou Demy, et al.
Published: (2020-05-01)

Serum Neurofilament Light concentrations are not associated with renal function in secondary progressive multiple sclerosis
by: T. Williams, et al.
Published: (2021-12-01)

Blood Neurofilament Light Chain: The Neurologist’s Troponin?
by: Simon Thebault, et al.
Published: (2020-11-01)

Cerebrospinal Fluid Neurofilament Light Chain Is Associated with Kynurenine Pathway Metabolite Changes in Multiple Sclerosis
by: Cecilia Rajda, et al.
Published: (2020-04-01)

Neurofilament light chain as a biological marker for multiple sclerosis: a meta-analysis study
by: Cai L, et al.
Published: (2018-09-01)

The Evolution of Neurofilament Light Chain in Multiple Sclerosis
by: Carolina Ferreira-Atuesta, et al.
Published: (2021-04-01)

A rapid review of differences in cerebrospinal neurofilament light levels in clinical subtypes of progressive multiple sclerosis
by: Haritha L. Desu, et al.
Published: (2024-04-01)

Serum Neurofilaments and OCT Metrics Predict EDSS-Plus Score Progression in Early Relapse-Remitting Multiple Sclerosis
by: Vlad Eugen Tiu, et al.
Published: (2023-02-01)

Serum Neurofilaments in Motor Neuron Disease and Their Utility in Differentiating ALS, PMA and PLS
by: Gavin McCluskey, et al.
Published: (2023-05-01)

Review of Neurofilaments as Biomarkers in Sepsis-Associated Encephalopathy
by: Zhang Q, et al.
Published: (2023-01-01)

Role of Blood Neurofilaments in the Prognosis of Amyotrophic Lateral Sclerosis: A Meta-Analysis
by: Yan-ni Zhou, et al.
Published: (2021-10-01)

Neurofilament Light Chain in Adult and Pediatric Multiple Sclerosis: A Promising Biomarker to Better Characterize Disease Activity and Personalize MS Treatment
by: Angelo Ghezzi, et al.
Published: (2023-09-01)

Serum Neurofilament Light Chain Measurement in MS: Hurdles to Clinical Translation
by: Simon Thebault, et al.
Published: (2021-03-01)

Editorial: The Impact of Neurofilament Light Chain (NFL) Quantification in Serum and Cerebrospinal Fluid in Neurodegenerative Diseases
by: Isabella Zanella, et al.
Published: (2022-05-01)

Multidimensional overview of neurofilament light chain contribution to comprehensively understanding multiple sclerosis
by: Rodolfo A. Kölliker Frers, et al.
Published: (2022-07-01)

Longitudinal Serum Neurofilament Levels of Multiple Sclerosis Patients Before and After Treatment with First-Line Immunomodulatory Therapies
by: André Huss, et al.
Published: (2020-08-01)

Application value of plasma Neurofilament light combined with magnetic resonance imaging to comprehensively evaluate multiple sclerosis activity and status
by: Feiyue Mi, et al.
Published: (2023-11-01)

Neurofilament light chain in the assessment of patients with multiple sclerosis
by: Renan Barros DOMINGUES, et al.

Value contribution of blood-based neurofilament light chain as a biomarker in multiple sclerosis using multi-criteria decision analysis
by: Enric Monreal, et al.
Published: (2024-04-01)

The prognostic significance of early blood neurofilament light chain concentration and magnetic resonance imaging variables in relapse‐onset multiple sclerosis
by: Thomas Williams, et al.
Published: (2022-09-01)

Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management
by: Mark S. Freedman, et al.
Published: (2024-03-01)

Cerebrospinal fluid neurofilament light chains and CXCL13 as predictive factors for clinical course of multiple sclerosis
by: Pavel Hradilek, et al.
Published: (2023-03-01)

Drug and Neurofilament Levels in Serum and Breastmilk of Women With Multiple Sclerosis Exposed to Natalizumab During Pregnancy and Lactation
by: Undine Proschmann, et al.
Published: (2021-08-01)

Brain disconnectome mapping derived from white matter lesions and serum neurofilament light levels in multiple sclerosis: A longitudinal multicenter study
by: Henning H. Rise, et al.
Published: (2022-01-01)

Sequencing of neurofilament genes identified NEFH Ser787Arg as a novel risk variant of sporadic amyotrophic lateral sclerosis in Chinese subjects
by: Feng Lin, et al.
Published: (2021-09-01)

Comparison of neurofilament light and heavy chain in spinal muscular atrophy and amyotrophic lateral sclerosis: A pilot study
by: Jin‐Yue Li, et al.
Published: (2023-05-01)

Serum Neurofilament Light Chain Levels are Associated with Lower Thalamic Perfusion in Multiple Sclerosis
by: Dejan Jakimovski, et al.
Published: (2020-09-01)

Diagnostic Performance of Neurofilaments in Chinese Patients With Amyotrophic Lateral Sclerosis: A Prospective Study
by: Da-Wei Li, et al.
Published: (2018-08-01)

Diagnostic and Prognostic Performance of Neurofilaments in ALS
by: Koen Poesen, et al.
Published: (2019-01-01)

Deciphering Multiple Sclerosis Progression
by: Virginia Meca-Lallana, et al.
Published: (2021-04-01)

Clinical stage and plasma neurofilament concentration in adults with Friedreich ataxia
by: Magnus Johnsson, et al.
Published: (2024-01-01)

Ella versus Simoa Serum Neurofilament Assessment to Monitor Treatment Response in Highly Active Multiple Sclerosis Patients
by: Martin Nötzel, et al.
Published: (2022-10-01)

Decreased Serum Neurofilament Light Chain and Fatigue Severity in Patients with Multiple Sclerosis after Home-Based and Outdoor Pilates Training
by: faranak Balaghi Inaloo, et al.
Published: (2023-05-01)

Neurofilaments Light Chain in Neurodegenerative Dementias: A Review of Imaging Correlates
by: Chiara Gallingani, et al.
Published: (2024-03-01)

Metabolomics detects clinically silent neuroinflammatory lesions earlier than neurofilament-light chain in a focal multiple sclerosis animal model
by: Tianrong Yeo, et al.
Published: (2022-10-01)

Assembly and turnover of neurofilaments in growing axonal neurites
by: Edward F. Boumil, et al.
Published: (2018-01-01)